Lifecore Biomedical to be Added to Nasdaq Biotech Index

Yahoo Finance Published Updated Stocks
Sign in to save

Affected assets and topics

NASDAQ MARKET

Why it matters

Lifecore Biomedical, a contract development and manufacturing organization, has been selected to be added to the Nasdaq Biotech Index, effective prior to market open on Monday, December 18, 2025.

Expected market reaction

Bullish Confidence 78% How confidence is read Impact: Moderate

Market impact analysis based on bullish sentiment with 78% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim Lifecore Biomedical to be Added to Nasdaq Biotech Index
AI inference Bullish · 78%
Generated 2025-12-18 12:00

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
23998

Original source

CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company’s stock is expected to be added to the Nasdaq Biotech Index (NASDAQ: NBI) as part of the annual reconstitution of the 2025 Nasdaq indexes. Lifecore’s inclusion in the Nasdaq Biotech Index will be effective prior to market open on Monday, December

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on December 18, 2025. Analysis and insights provided by AnalystMarkets AI.

Related coverage

This model on similar stories

Llama 3.1 8B Instant (Groq) · 37.9% correct across 177 scored calls on equities See the full record